Abstract

Insights

Macrophage migration inhibitory factor (MIF), NF-κB p65, and IL-1β are elevated in nasal polyps, suggesting they promote disease development. MIF and NF-κB p65 levels can indicate nasal polyp severity and prognosis.

Area of Science:

  • Otorhinolaryngology
  • Immunology
  • Molecular Biology

Background:

  • Nasal polyps are inflammatory growths in the nasal cavity.
  • The roles of Macrophage Migration Inhibitory Factor (MIF), Nuclear Factor kappa B p65 (NF-κB p65), and Interleukin-1 beta (IL-1β) in nasal polyps are not fully understood.

Purpose of the Study:

  • To investigate the expression levels of MIF, NF-κB p65, and IL-1β in nasal polyps and normal inferior turbinate tissues.
  • To analyze the correlations between these factors and their relevance to nasal polyp development.
  • To explore the potential role of these molecules in the pathogenesis of nasal polyps.

Main Methods:

  • Immunohistochemistry was used to detect MIF, NF-κB p65, and IL-1β expression in 48 nasal polyp tissues and 21 normal inferior turbinate tissues.
  • Hematoxylin and eosin (HE) staining assessed inflammatory cell infiltration, particularly eosinophils (EOS).
  • Correlation analyses (Spearman) were performed between the expression levels of these factors and clinical severity scores (VAS, Lund-Kennedy).

Main Results:

  • Nasal polyp tissues showed significantly higher infiltration of EOS and elevated expression of MIF, NF-κB p65, and IL-1β compared to controls (P < 0.05).
  • MIF, NF-κB p65, and IL-1β expression levels were positively correlated with each other.
  • MIF and NF-κB p65 nuclear activation rate correlated with nasal polyp severity scores, suggesting their role as potential biomarkers.

Conclusions:

  • MIF, NF-κB p65, and IL-1β are implicated in the development and progression of nasal polyps.
  • A potential IL-1β–NF-κB–MIF pathway may exist in nasal polyps.
  • MIF and NF-κB p65 may serve as indicators for assessing nasal polyp severity and predicting prognosis.

Related Concept Videos

NF-&#954;B-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.2K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

2.4K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
709
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K